サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676283

院内感染症検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Hospital Acquired Disease Testing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 162 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
院内感染症検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 162 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

院内感染症検査の世界市場規模は、2024年の154億8,000万米ドルから、2033年までには663億米ドルに成長すると予測され、2026年から2033年の予測期間中に17.54％の堅調な年間平均成長率（CAGR）を示します。

院内感染症検査市場は、ヘルスケア関連感染症（HAI）の発生率の増加や、患者の安全性とケアの質の重視の高まりに牽引され、堅調な成長を遂げるものと思われます。病院やヘルスケア施設がHAIのリスクを最小限に抑えようと努力する中で、正確で迅速な診断検査法の需要が最も重要になってきています。抗生物質耐性病原体の増加は状況をさらに複雑にしており、感染症の原因物質を迅速に特定し、適切な治療戦略を導くことができる高度な検査ソリューションが必要とされています。HAIが患者の転帰とヘルスケアコストに与える影響に対する意識の高まりが、市場を前進させています。

診断検査における技術の進歩は、院内感染症検査市場に革命をもたらしています。分子診断、ポイントオブケア検査、次世代シークエンシングなどの技術革新により、病原体検出のスピードと精度が向上しています。これらの技術により、ヘルスケアプロバイダーはタイムリーな介入を実施し、入院期間を短縮し、患者の転帰全体を改善することができます。さらに、電子カルテや検査情報システムなどのデジタルヘルスソリューションの統合により、データ管理が合理化され、ヘルスケアチーム間のコミュニケーションが円滑になり、感染対策の効率がさらに向上しています。

さらに、院内感染症検査市場は、HAI削減を目的とした規制当局の監視や公衆衛生イニシアチブの強化からも恩恵を受けると思われます。ヘルスケア機関が厳格な感染防止プロトコルを採用するにつれて、包括的な検査ソリューションに対する需要が高まると思われます。標準化された検査ガイドラインを開発し、ベストプラクティスを広く普及させるには、診断会社、ヘルスケアプロバイダー、規制機関の協力が不可欠となります。市場が発展するにつれて、検査はより広範な感染管理戦略に組み込まれ、院内感染対策におけるサーベイランス、早期発見、標的介入の重要性が強調されるようになると考えられています。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳します。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価をします。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 院内感染症検査産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル開発動向

第5章 院内感染症検査の世界市場分析：検査タイプ別

  • 概要：検査タイプ別
  • 実績データと予測データ分析：検査タイプ別
  • 尿路感染
  • 手術部位感染
  • 肺炎ステント
  • 血流感染
  • メチシリン耐性黄色ブドウ球菌
  • その他

第6章 院内感染症検査の世界市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 実績データと予測データ分析：エンドユーザー別
  • 病院・集中治療室（ICUS）
  • 外来手術センター・診断センター
  • 老人ホーム・マタニティセンター
  • 企業

第7章 院内感染症検査の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第8章 院内感染症検査企業の競合情勢

  • 院内感染症検査市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott
  • Eurofins Scientific
  • BIOMÉRIEUX
  • Cantel Medical
  • Meridian Bioscience Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • BD
  • Hologic Inc.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
  • Medtronic
  • Getinge AB
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Test Type (Units and USD MN)
  • Urinary Tract Infection Market Sales By Geography (Units and USD MN)
  • Surgical Site Infection Market Sales By Geography (Units and USD MN)
  • Pneumonia Stents Market Sales By Geography (Units and USD MN)
  • Blood Stream Infection Market Sales By Geography (Units and USD MN)
  • Methicillin-Resistant Staphylococcus Aureus Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Analysis By End User (Units and USD MN)
  • Hospitals and Intensive Care Units (ICUS) Market Sales By Geography (Units and USD MN)
  • Ambulatory Surgical and Diagnostic Centers Market Sales By Geography (Units and USD MN)
  • Nursing Homes and Maternity Centers Market Sales By Geography (Units and USD MN)
  • Companies Market Sales By Geography (Units and USD MN)
  • Global Hospital Acquired Disease Testing Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hospital Acquired Disease Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Hospital Acquired Disease Testing Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Test Type (Units and USD MN)
  • Urinary Tract Infection Market Sales By Geography (Units and USD MN)
  • Surgical Site Infection Market Sales By Geography (Units and USD MN)
  • Pneumonia Stents Market Sales By Geography (Units and USD MN)
  • Blood Stream Infection Market Sales By Geography (Units and USD MN)
  • Methicillin-Resistant Staphylococcus Aureus Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By End User (Units and USD MN)
  • Hospitals and Intensive Care Units (ICUS) Market Sales By Geography (Units and USD MN)
  • Ambulatory Surgical and Diagnostic Centers Market Sales By Geography (Units and USD MN)
  • Nursing Homes and Maternity Centers Market Sales By Geography (Units and USD MN)
  • Companies Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11213861

Global Hospital Acquired Disease Testing Market size is anticipated to grow from USD 15.48 Billion in 2024 to USD 66.3 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.54% during the forecast period of 2026 to 2033.

The hospital-acquired disease testing market is set to experience robust growth, driven by the increasing incidence of healthcare-associated infections (HAIs) and the growing emphasis on patient safety and quality of care. As hospitals and healthcare facilities strive to minimize the risk of HAIs, the demand for accurate and rapid diagnostic testing methods is becoming paramount. The rise in antibiotic-resistant pathogens further complicates the landscape, necessitating advanced testing solutions that can quickly identify the causative agents of infections and guide appropriate treatment strategies. This growing awareness of the impact of HAIs on patient outcomes and healthcare costs is propelling the market forward.

Technological advancements in diagnostic testing are revolutionizing the hospital-acquired disease testing market. Innovations such as molecular diagnostics, point-of-care testing, and next-generation sequencing are enhancing the speed and accuracy of pathogen detection. These technologies enable healthcare providers to implement timely interventions, reducing the duration of hospital stays and improving overall patient outcomes. Additionally, the integration of digital health solutions, including electronic health records and laboratory information systems, is streamlining data management and facilitating better communication among healthcare teams, further enhancing the efficiency of infection control measures.

Moreover, the hospital-acquired disease testing market will benefit from increased regulatory scrutiny and public health initiatives aimed at reducing HAIs. As healthcare organizations adopt stringent infection prevention protocols, the demand for comprehensive testing solutions will rise. Collaborative efforts between diagnostic companies, healthcare providers, and regulatory bodies will be essential in developing standardized testing guidelines and ensuring the widespread adoption of best practices. As the market evolves, the focus will shift towards integrating testing into broader infection control strategies, emphasizing the importance of surveillance, early detection, and targeted interventions in combating hospital-acquired diseases.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Test Type

  • Urinary Tract Infection
  • Surgical Site Infection
  • Pneumonia Stents
  • Blood Stream Infection
  • Methicillin-Resistant Staphylococcus Aureus
  • Others

By End User

  • Hospitals and Intensive Care Units (ICUS)
  • Ambulatory Surgical and Diagnostic Centers
  • Nursing Homes and Maternity Centers
  • Companies
  • COMPANIES PROFILED
  • Abbott
  • Eurofins Scientific
  • BIOMERIEUX
  • Cantel Medical
  • Meridian Bioscience Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • BD
  • Hologic Inc.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
  • Medtronic
  • Getinge AB
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE

  • 5.1. Overview By Test Type
  • 5.2. Historical and Forecast Data Analysis By Test Type
  • 5.3. Urinary Tract Infection Historic and Forecast Sales By Regions
  • 5.4. Surgical Site Infection Historic and Forecast Sales By Regions
  • 5.5. Pneumonia Stents Historic and Forecast Sales By Regions
  • 5.6. Blood Stream Infection Historic and Forecast Sales By Regions
  • 5.7. Methicillin-Resistant Staphylococcus Aureus Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY END USER

  • 6.1. Overview By End User
  • 6.2. Historical and Forecast Data Analysis By End User
  • 6.3. Hospitals and Intensive Care Units (ICUS) Historic and Forecast Sales By Regions
  • 6.4. Ambulatory Surgical and Diagnostic Centers Historic and Forecast Sales By Regions
  • 6.5. Nursing Homes and Maternity Centers Historic and Forecast Sales By Regions
  • 6.6. Companies Historic and Forecast Sales By Regions

7. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES

  • 8.1. Hospital Acquired Disease Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Eurofins Scientific
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. BIOMÉRIEUX
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Cantel Medical
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Meridian Bioscience Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. QIAGEN
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. F. Hoffmann-La Roche Ltd
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. BD
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Hologic Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Siemens Healthcare Private Limited
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Thermo Fisher Scientific Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Medtronic
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Getinge AB
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies